Lazard Transactions
DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided
Download results
Showing 531 to 540 of 5771 Results
March 06, 2024
Mistertemp’ group announces the reorganization of its shareholding: Andera Partners succeeds Montefiore Investment
Undisclosed
March 06, 2024
Wynnchurch Capital Closes on Fund VI at $3.5 Billion
$3.5 Billion
March 06, 2024
Platinum Equity Invests in TAK Communications
Undisclosed
March 05, 2024
Recommended all-share merger of LXi and LondonMetric
$2.3 Billion
March 04, 2024
Lazard advises Pollen Street Capital on a €1 billion continuation fund
$1 Billion
March 01, 2024
Kinnate Biopharma Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre
$31 Million
March 01, 2024
Etex reinforces its position in Australia by acquiring BGC’s plasterboard and fibre cement businesses
Undisclosed
February 28, 2024
Investment in Tele2 From Freya Investissement (Iliad & NJJ Holding)
$1.2 Billion
February 28, 2024
Initiative & Finance acquires Ocellis from Turenne Capital
Undisclosed
February 27, 2024